Literature DB >> 15027902

Toll-like receptor 2 (TLR2) and TLR4 are present inside human dendritic cells, associated with microtubules and the Golgi apparatus but are not detectable on the cell surface: integrity of microtubules is required for interleukin-12 production in response to internalized bacteria.

Heli Uronen-Hansson1, Jennifer Allen, Mohamed Osman, Ginette Squires, Nigel Klein, Robin E Callard.   

Abstract

The activation of dendritic cells (DCs) by microbes is mediated by pattern recognition receptors including the Toll-like receptors (TLR). Bacterial lipopolysaccharide acts via TLR4 whereas peptidoglycan and lipoprotein responses are mediated by TLR2. It is generally accepted that TLR binding to microbes occurs at the cell surface but this has not been directly demonstrated for human DCs. We show here that TLR2 and TLR4 are expressed inside DCs in an abundant tubulovesicular pattern with a focus of intense staining adjacent to the nucleus. In contrast, there was no detectable expression on the cell surface. TLR2 and TLR4 were readily found both intracellularly and on the surface of monocytes. They were shown to be closely associated with the Golgi complex and colocalized with alpha-tubulin, displaying a high focal concentration at the microtubule organizing centre. Alignment of TLR2 and TLR4 with microtubules was observed, suggesting that microtubules serve as transport tracks for TLR vesicles. Depolymerization of the microtubule network disrupted the intracellular expression of TLR2 and TLR4 and profoundly inhibited interleukin-12 (IL-12) production in response to Neisseria meningitidis but did not prevent phagocytosis. These data are consistent with the bacterial signalling through TLR2 and TLR4 required for IL-12 production occurring inside DCs after phagocytosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15027902      PMCID: PMC1782406          DOI: 10.1111/j.0019-2805.2003.01803.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  32 in total

Review 1.  Dendritic cells: a link between innate and adaptive immunity.

Authors:  K Palucka; J Banchereau
Journal:  J Clin Immunol       Date:  1999-01       Impact factor: 8.317

2.  Differential roles of TLR2 and TLR4 in the host response to Gram-negative bacteria: lessons from a lipopolysaccharide-deficient mutant of Neisseria meningitidis.

Authors:  R R Ingalls; E Lien; D T Golenbock
Journal:  J Endotoxin Res       Date:  2000

3.  Outer membrane composition of a lipopolysaccharide-deficient Neisseria meningitidis mutant.

Authors:  L Steeghs; H de Cock; E Evers; B Zomer; J Tommassen; P van der Ley
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

Review 4.  Toll-like receptors: how they work and what they do.

Authors:  Bruce Beutler
Journal:  Curr Opin Hematol       Date:  2002-01       Impact factor: 3.284

Review 5.  Antigen presentation and T cell stimulation by dendritic cells.

Authors:  Pierre Guermonprez; Jenny Valladeau; Laurence Zitvogel; Clotilde Théry; Sebastian Amigorena
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

Review 6.  The Toll receptor family.

Authors:  M Muzio; A Mantovani
Journal:  Allergy       Date:  2001-02       Impact factor: 13.146

7.  Dendritic cell activation and cytokine production induced by group B Neisseria meningitidis: interleukin-12 production depends on lipopolysaccharide expression in intact bacteria.

Authors:  G L Dixon; P J Newton; B M Chain; D Katz; S R Andersen; S Wong; P van der Ley; N Klein; R E Callard
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

8.  Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines.

Authors:  Kol A Zarember; Paul J Godowski
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

9.  Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses.

Authors:  Ian Sabroe; Elizabeth C Jones; Lynne R Usher; Moira K B Whyte; Steven K Dower
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

10.  Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells.

Authors:  Mathias W Hornef; Teresa Frisan; Alain Vandewalle; Staffan Normark; Agneta Richter-Dahlfors
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

View more
  33 in total

Review 1.  The potential for Toll-like receptors to collaborate with other innate immune receptors.

Authors:  Subhankar Mukhopadhyay; Jurgen Herre; Gordon D Brown; Siamon Gordon
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

Review 2.  Sensing of RNA viruses: a review of innate immune receptors involved in recognizing RNA virus invasion.

Authors:  Søren Jensen; Allan Randrup Thomsen
Journal:  J Virol       Date:  2012-01-18       Impact factor: 5.103

3.  Phagocytes containing a disease-promoting Toll-like receptor/Nod ligand are present in the brain during demyelinating disease in primates.

Authors:  Lizette Visser; Marie-José Melief; Debby van Riel; Marjan van Meurs; Ella A Sick; Seiichi Inamura; Jeffrey J Bajramovic; Sandra Amor; Rogier Q Hintzen; Leonie A Boven; Bert A 't Hart; Jon D Laman
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

4.  Toll-like receptors 3, 4, and 7 are expressed in the enteric nervous system and dorsal root ganglia.

Authors:  Isabella Barajon; Graziano Serrao; Francesca Arnaboldi; Emanuela Opizzi; Gerlomina Ripamonti; Andrea Balsari; Cristiano Rumio
Journal:  J Histochem Cytochem       Date:  2009-06-22       Impact factor: 2.479

5.  Blockade of CD137 signaling counteracts polymicrobial sepsis induced by cecal ligation and puncture.

Authors:  Quang-Tam Nguyen; Seong-A Ju; Sang-Min Park; Sang-Chul Lee; Hideo Yagita; In Hee Lee; Byung-Sam Kim
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

6.  EF24 suppresses maturation and inflammatory response in dendritic cells.

Authors:  Prachi Vilekar; Shanjana Awasthi; Aravindan Natarajan; Shrikant Anant; Vibhudutta Awasthi
Journal:  Int Immunol       Date:  2012-02-29       Impact factor: 4.823

7.  A self-adjuvanting lipopeptide-based vaccine candidate for the treatment of hepatitis C virus infection.

Authors:  Brendon Y Chua; Emily M Eriksson; Lorena E Brown; Weiguang Zeng; Eric J Gowans; Joseph Torresi; David C Jackson
Journal:  Vaccine       Date:  2008-04-07       Impact factor: 3.641

8.  Differential effects of Paclitaxel on dendritic cell function.

Authors:  Justin John; Mohammed Ismail; Catherine Riley; Jonathan Askham; Richard Morgan; Alan Melcher; Hardev Pandha
Journal:  BMC Immunol       Date:  2010-03-19       Impact factor: 3.615

9.  SPLUNC1 regulation in airway epithelial cells: role of Toll-like receptor 2 signaling.

Authors:  Hong Wei Chu; Fabienne Gally; Jyoti Thaikoottathil; Yvonne M Janssen-Heininger; Qun Wu; Gongyi Zhang; Nichole Reisdorph; Stephanie Case; Maisha Minor; Sean Smith; Di Jiang; Nicole Michels; Glenn Simon; Richard J Martin
Journal:  Respir Res       Date:  2010-11-05

10.  Toll-like receptor regulation of intestinal development and inflammation in the pathogenesis of necrotizing enterocolitis.

Authors:  Peng Lu; Chhinder P Sodhi; David J Hackam
Journal:  Pathophysiology       Date:  2013-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.